Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
510PDF: 1578Supplementary: 195Appendix: 141HTML: 14 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1013pdf: 204Supplementary Material: 35HTML: 76 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
692PDF: 162Supplementary: 133Appendix: 104HTML: 1 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
698PDF: 154Supplementary: 140Appendix: 103HTML: 6 -
-
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1825PDF: 483SUPPLEMENTARY MATERIAL: 291GRAPHICAL ABSTRACT: 258HTML: 4 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
53PDF: 97Supplementary: 60HTML: 5 -
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1055PDF: 225Supplementary: 150HTML: 66 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2252PDF: 616Conflict of interest: 309SUPPLEMENTARY MATERIAL: 248HTML: 25 -
Epidemiology of peripartum cardiomyopathy in Africa
2119PDF: 467HTML: 33 -
Evolving targets for heart failure: the journey so far
1917pdf: 269HTML: 4